The Influence of the Thickening of Bowman's Capsule on the Clinical Prognosis of Patients With Diabetic Kidney Disease
- Conditions
- Diabetic Kidney DiseaseExtracellular Matrix Alteration
- Interventions
- Other: no intervention
- Registration Number
- NCT06049550
- Lead Sponsor
- RenJi Hospital
- Brief Summary
Diabetic kidney disease (DKD) is the leading cause for renal replacement therapy in developed country. DKD is also the primary cause of ESKD among middle-aged and elderly people in China. Renal pathological markers have been proved to have clinical and prognostic value in both non diabetic and diabetic kidney diseases. To discriminate lesions by various degrees of severity, the Working Group of the Renal Pathology Society (RPS) developed a pathologic classification for DKD in 2010. The classification is based on glomerular lesions, with a separate evaluation for interstitial and vascular lesions. In a decade, there were several new characteristics common to DKD, such as the presence of mesangiolysis, glomerular hyalinosis, segmental sclerosis and extracapillary hypercellularity, which have been noted in patients with diabetes and may have prognostic importance. But it is still unclear whether thickening of Bowman's capsule predicts the progression of DKD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 250
-
- Age ≥ 18 years old, male or female 2) Patients diagnosed as diabetes kidney disease by renal biopsy
-
- Patients combined with non diabetes kidney disease; 2) Patients with kidney transplant failure; 3) Patients undergoing zero point puncture for kidney transplantation; 4) less than 5 glomeruli in the renal puncture sample.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description mild thicknening of Bowman's Capsule no intervention - severe thickening of Bowman's Capsule no intervention -
- Primary Outcome Measures
Name Time Method renal failure From the diagnosis of diabetes kidney disease by renal biopsy to December 31, 2022 estimated glomerular filtration rate(eGFR)\<15ml/min/1.73m2, renal replacement treatment or death caused by renal disease
- Secondary Outcome Measures
Name Time Method